41270-67-1

Usage

Uses

Used in Pharmaceutical Synthesis:
3-Phenylpyrazinamine serves as an essential intermediate in the synthesis of various pharmaceutical compounds. Its unique structure allows it to be a key component in the development of new drugs.
Used in Agrochemical Production:
In addition to pharmaceuticals, 3-Phenylpyrazinamine is utilized as an intermediate in the production of agrochemicals, contributing to the development of pesticides and other agricultural products.
Used in Antimicrobial Applications:
3-Phenylpyrazinamine is studied for its potential antimicrobial properties, making it a candidate for use in applications that require the inhibition of microbial growth.
Used in Anti-inflammatory Applications:
3-PHENYLPYRAZINAMINE is also being investigated for its anti-inflammatory capabilities, which could lead to its use in treatments for various inflammatory conditions.
Used in Antitumor Research:
3-Phenylpyrazinamine's potential antitumor properties are of interest to researchers, who are exploring its use in cancer treatment and therapy.

Upstream product

• 7677-24-9 trimethylsilyl cyanide 
• 100-52-7 benzaldehyde 
• 107-15-3 ethylenediamine 
• 21943-12-4 3-bromo-pyrazine-2-amine 
• 98-80-6 phenylboronic acid 
• 41270-65-9 2-chloro-3-phenylpyrazine 
• 156331-29-2 2-azido-3-phenylpyrazine 

Downstream Products

• 344940-70-1 5-bromo-3-phenyl-pyrazin-2-amine 
• 103965-78-2 1-Oxy-3-phenyl-pyrazin-2-ylamine 
• 116114-63-7 2-Benzamido-3-phenylpyrazine 

Relevant academic research and scientific papers

ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME

An organic light-emitting device includes: a first electrode; a second electrode facing the first electrode; and an organic layer between the first electrode and the second electrode, the organic layer including an emission layer. The emission layer includes at least one organometallic compound of Formula 1, and at least one selected from a second compound and a third compound, where the organometallic compound, the second compound, and the third compound are different from each other. When the emission layer comprises both the second compound and the third compound, the second compound and the third compound form an exciplex, and the organometallic compound and the second compound and/or the third compound do not form an exciplex: [in-line-formulae]M(L1)n1(L2)n2,??Formula 1[/in-line-formulae] wherein in Formula 1, L1 is represented by Formula 2-1:

A reaction of 1,2-diamines and aldehydes with silyl cyanide as cyanide pronucleophile to access 2-aminopyrazines and 2-aminoquinoxalines

A new condensation reaction of ethylene-1,2-diamines or o-phenylenediamines and aromatic aldehydes with TMSCN as a cyanide-pronucleophile is documented. The reaction proceeds through a tandem sequence of desilylation, Strecker reaction, amidine-forming cy

Studies on pyrazines; part 30: Synthesis of aminopyrazines from azidopyrazines

Azidopyrazines do not undergo reduction by reagents that are effective for the preparation of alkyl- or arylamines from the azides because the heterocyclic azides exist in the bicyclic form of tetrazolo[1,5-a]pyrazines. Nevertheless, the conversion into aminopyrazines was achieved by hydrogenolysis in the presence of ammonium hydroxide and palladium-on-carbon or particularly by reduction with tin(II) chloride in methanolic hydrochloric acid, in 34-87% yields. To elucidate the successful progress of the reaction, the equilibrium of azide-atetrazole was examined by 1H NMR spectroscopy in various solvents.